BioNTech SEBNTXNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+287.7%
5Y CAGR+50.8%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+287.7%/yr
Quarterly compound
5Y CAGR
+50.8%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
7.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 482.40% |
| Q2 2025 | 42.67% |
| Q1 2025 | -84.64% |
| Q4 2024 | -4.40% |
| Q3 2024 | 867.21% |
| Q2 2024 | -31.40% |
| Q1 2024 | -87.32% |
| Q4 2023 | 65.20% |
| Q3 2023 | 433.87% |
| Q2 2023 | -86.87% |
| Q1 2023 | -70.15% |
| Q4 2022 | 23.61% |
| Q3 2022 | 8.28% |
| Q2 2022 | -49.86% |
| Q1 2022 | 15.22% |
| Q4 2021 | -9.11% |
| Q3 2021 | 14.67% |
| Q2 2021 | 159.15% |
| Q1 2021 | 492.98% |
| Q4 2020 | 411.77% |
| Q3 2020 | 61.87% |
| Q2 2020 | 50.54% |
| Q1 2020 | -1.03% |
| Q4 2019 | -2.35% |
| Q3 2019 | 11.16% |
| Q2 2019 | -1.41% |
| Q1 2019 | -58.99% |
| Q4 2018 | 212.69% |
| Q3 2018 | -6.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |